Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BufferGel with diaphragm for contraception
NCT00397670Phase 3Completed
- Sponsor
- ReProtect Inc
- Start
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of buffergel in pregnancy, sponsored by ReProtect Inc. Started Jan 2004; status: completed.
02
Drugs
buffergel
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00397670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397670.